• Prostaglandin E2 in Inflammation Research: Protocols & Insig

  2026-05-24

  Prostaglandin E2 (PGE2) offers unique advantages for dissecting inflammation pathways and immune regulation with high specificity and reproducibility. This article unpacks applied workflows, experimental enhancements, and troubleshooting tips, translating recent advances and literature-backed protocols into actionable guidance for bench scientists.

• Cdk5 Inhibition Reduces Ferroptosis via AMPK and Microglial

  2026-05-23

  This study elucidates how downregulating Cdk5 reverses ferroptosis in hippocampal neurons after ischemic stroke by modulating the AMPK pathway and M1 microglial polarization. The findings provide mechanistic insights that could inform targeted interventions for neuroprotection and iron metabolism research.

• Excessive Calpain Impairs Offspring Cognition via BDNF/TrkB

  2026-05-22

  The referenced study demonstrates that maternal non-obstetric surgery during pregnancy leads to excessive calpain activation, which disrupts BDNF/TrkB signaling and impairs cognitive development in offspring. Pharmacological calpain inhibition or TrkB activation partially rescues these deficits, highlighting new research avenues in neuroprotection and developmental neuroscience.

• Fluorouracil in Solid Tumor Research: Protocols, Pitfalls &

  2026-05-22

  Fluorouracil (Adrucil) remains the backbone for solid tumor research by enabling precise inhibition of DNA replication in colon, breast, and other cancers. This guide demystifies optimized workflows, troubleshooting, and new translational insights, helping researchers maximize experimental reliability and relevance.

• Applied Use of PPT (Propyl Pyrazole Triol) in ERα Research

  2026-05-21

  PPT (Propyl Pyrazole Triol) empowers high-fidelity, ERα-selective signaling studies that drive reproducible results in hormone biology and cancer research. This guide translates advanced bench protocols, comparative advantages, and troubleshooting tips—grounded in recent biomarker discoveries—into actionable workflows for biomedical scientists.

• Dextromethorphan Hydrobromide: Optimizing NMDA Antagonist Wo

  2026-05-21

  Dextromethorphan hydrobromide from APExBIO empowers neuroprotection research with precise NMDA receptor antagonism and robust ion channel modulation. This guide details evidence-driven workflows, troubleshooting tips, and translational strategies for maximizing reproducibility and impact in excitotoxicity and cerebral ischemia models.

• ω-Agatoxin IVA TFA in Synaptic Transmission & Epilepsy Model

  2026-05-20

  ω-Agatoxin IVA TFA offers nanomolar-specific Cav2.1 channel inhibition, powering precision in neuronal calcium current recording and epilepsy animal model workflows. Its selectivity and robust neuroprotective profile, supplied by APExBIO, drive advanced applications and troubleshooting strategies in neurophysiology research.

• Pexmetinib (ARRY-614): Advanced Workflows for Cytokine Inhib

  2026-05-20

  Pexmetinib (ARRY-614) delivers dual p38 MAPK and Tie2 inhibition, enabling reproducible suppression of inflammatory cytokines and precise pathway dissection in myelodysplastic and inflammatory models. This guide translates recent structural and mechanistic breakthroughs into actionable protocols, troubleshooting, and application strategies for translational researchers.

• MMP7 Drives EMT and Fibrosis via E-cadherin/β-Catenin in BA

  2026-05-19

  This study elucidates how matrix metalloproteinase 7 (MMP7) promotes epithelial–mesenchymal transition (EMT) and liver fibrosis in biliary atresia by cleaving E-cadherin and activating β-catenin signaling. The findings position MMP7 as a mechanistic link between EMT and fibrotic progression, highlighting new therapeutic targets for pediatric liver disease.

• TSPAN18 Stabilizes STIM1 to Drive Bone Metastasis in Prostat

  2026-05-19

  Zhou et al. uncover a novel regulatory axis in prostate cancer bone metastasis, demonstrating that TSPAN18 stabilizes STIM1 by inhibiting its ubiquitination via TRIM32, thereby amplifying calcium signaling essential for metastatic progression. This mechanistic insight highlights TSPAN18 as a potential therapeutic target and informs future research into hormone-responsive cancer pathways.

• Abiraterone Acetate: CYP17 Inhibitor Workflows in Prostate C

  2026-05-18

  Unlock the full translational potential of Abiraterone acetate, a potent CYP17 inhibitor, in advanced 3D spheroid and in vivo prostate cancer models. This guide delivers actionable protocols, troubleshooting insights, and experimental strategies to enhance reliability and discovery in androgen biosynthesis pathway research.

• Dehydroepiandrosterone (DHEA): Optimizing Neuroprotection an

  2026-05-18

  APExBIO’s Dehydroepiandrosterone (DHEA) empowers advanced neuroprotection and ovarian dysfunction research with validated, reproducible protocols. This guide translates cutting-edge findings and troubleshooting strategies into actionable workflows, driving reliability and impact in apoptosis inhibition, granulosa cell proliferation, and hippocampal neuron protection studies.

• BX795: Precision PDK1 Inhibition in Translational Oncology

  2026-05-17

  This thought-leadership article explores the mechanistic, experimental, and strategic considerations of using BX795 as a PDK1 inhibitor in cancer and innate immunity research. Integrating recent advances in in vitro drug response evaluation, it provides translational researchers with actionable guidance for maximizing the impact of BX795—including protocol recommendations, comparative analysis, and evidence-driven outlook.

• Salmonella Targets FAM134B to Suppress ER-Phagy and Enhance

  2026-05-16

  This study reveals how Salmonella Typhimurium subverts host ER-phagy by targeting the FAM134B receptor, promoting bacterial survival. The findings clarify a key immune evasion mechanism and identify FAM134B as a pivotal host factor in pathogen defense, with implications for phosphoprotein analysis in autophagy research.

• Caspase-3/ERO1α Axis Drives Mitochondrial ROS in Trichothece

  2026-05-15

  This study elucidates how trichothecene mycotoxins provoke hepatotoxicity via a caspase-3-driven cleavage of mitochondrial NDUFS1, amplifying mitochondrial ROS, with ER-localized ERO1α acting as a parallel source of oxidative stress. The findings uncover a positive feedback loop between mitochondrial and ER-derived ROS, providing mechanistic insight into mycotoxin-induced liver injury and highlighting new intervention points.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page